David serves as a Managing Director and Head of M&A, US. He has experience advising public and private companies in domestic and cross-border transactions involving corporate sales, divestitures, acquisitions, joint ventures, takeover defense, shareholder activism, leveraged buyouts/recapitalizations, stock buybacks and spinoffs. David has approximately 25 years of M&A experience and joined Canaccord Genuity in 2014 from Cowen and Company, where he served as Managing Director and Head of Technology M&A. Before that, he was a senior member of the M&A teams at UBS Investment Bank and PaineWebber Incorporated and a Founder and Managing Member of the technology-focused venture capital fund Bluefish Ventures. David graduated cum laude from The Wharton School at the University of Pennsylvania with a B.S. in Economics and concentration in Finance.
Selected Transactions
-
Neuronetics
Financial Advisor to Neuronetics on its Announced Merger with Greenbrook TMS
-
US$324m
AdTheorent
Exclusive Financial Advisor to AdTheorent Holding Company on its Sale to Cadent
-
US$680m
Thorne HealthTech
Exclusive Financial Advisor (Sell side)
-
TransMedics
Financial Advisor (Buy side)
-
Calyxt
Financial Advisor (Merger)
-
Winc
Investment Banker (Chapter 11 Restructuring)
-
US$1.2b
Environmental Impact Acquisition Corp.
Financial Advisor on Merger with GreenLight Biosciences
-
N/a
EPAM Systems, Inc.
Financial Advisor to EPAM Systems, Inc. on its Acquisition of Emakina Group
-
Newtown Lane Marketing
Newtown Lane Marketing
Financial Advisor